Literature DB >> 18207116

Cognition and diabetes: a lifespan perspective.

Geert Jan Biessels1, Ian J Deary, Christopher M Ryan.   

Abstract

Diabetes mellitus is associated with cognitive dysfunction and abnormalities that can be seen with brain imaging. Recent studies provide important new insights into the nature and severity of these cerebral complications that help to explain why some patients with diabetes have clinically relevant neurocognitive morbidity, whereas most are apparently unaffected. This Personal View investigates the hypothesis that clinically relevant diabetes-related cognitive decrements mainly occur at two crucial periods in life: when the brain is developing in childhood, and when the brain undergoes neurodegenerative changes associated with ageing. Outside of these periods cognitive decrements mainly occur in patients with notable diabetes-related comorbidities, in particular microvascular or macrovascular complications. The identification of crucial periods and conditions for the development of diabetes-related cognitive decrements helps to draw the attention of physicians to individuals at risk and can direct future studies into the mechanisms that underlie these conditions.

Entities:  

Mesh:

Year:  2008        PMID: 18207116     DOI: 10.1016/S1474-4422(08)70021-8

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  209 in total

1.  Differential effects of treadmill exercise in early and chronic diabetic stages on parvalbumin immunoreactivity in the hippocampus of a rat model of type 2 diabetes.

Authors:  In Koo Hwang; Sun Shin Yi; Ki-Yeon Yoo; Ok Kyu Park; Bingchun Yan; Wook Song; Moo-Ho Won; Yeo Sung Yoon; Je Kyung Seong
Journal:  Neurochem Res       Date:  2011-04-24       Impact factor: 3.996

2.  Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy.

Authors:  Lenore J Launer; Michael E Miller; Jeff D Williamson; Ron M Lazar; Hertzel C Gerstein; Anne M Murray; Mark Sullivan; Karen R Horowitz; Jingzhong Ding; Santica Marcovina; Laura C Lovato; James Lovato; Karen L Margolis; Patrick O'Connor; Edward W Lipkin; Joy Hirsch; Laura Coker; Joseph Maldjian; Jeffrey L Sunshine; Charles Truwit; Christos Davatzikos; R Nick Bryan
Journal:  Lancet Neurol       Date:  2011-09-28       Impact factor: 44.182

3.  Polygenic Risk of Schizophrenia and Cognition in a Population-Based Survey of Older Adults.

Authors:  David T Liebers; Mehdi Pirooznia; Fayaz Seiffudin; Katherine L Musliner; Peter P Zandi; Fernando S Goes
Journal:  Schizophr Bull       Date:  2016-02-12       Impact factor: 9.306

4.  Metabolic control and academic achievement over time among adolescents with type 1 diabetes.

Authors:  Joel B Winnick; Cynthia A Berg; Deborah J Wiebe; Barbara A Schaefer; Pui-Wa Lei; Jonathan E Butner
Journal:  Sch Psychol Q       Date:  2017-01-12

5.  Cooccurrence of vascular risk factors and late-life white-matter integrity changes.

Authors:  Pauline Maillard; Owen T Carmichael; Bruce Reed; Dan Mungas; Charles DeCarli
Journal:  Neurobiol Aging       Date:  2015-01-14       Impact factor: 4.673

Review 6.  Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?

Authors:  Kawser Akter; Emily A Lanza; Stephen A Martin; Natalie Myronyuk; Melanie Rua; Robert B Raffa
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

7.  Aminoguanidine changes hippocampal expression of apoptosis-related genes, improves passive avoidance learning and memory in streptozotocin-induced diabetic rats.

Authors:  Maryam Arab Firouzjaei; Mohammad Reza Jafari; Mehdi Eskandari; Iraj Jafari Anarkoli; Mohsen Alipour
Journal:  Cell Mol Neurobiol       Date:  2013-12-11       Impact factor: 5.046

Review 8.  Vascular risk factors and dementia: how to move forward?

Authors:  Anand Viswanathan; Walter A Rocca; Christophe Tzourio
Journal:  Neurology       Date:  2009-01-27       Impact factor: 9.910

9.  Gallic acid modulates cerebral oxidative stress conditions and activities of enzyme-dependent signaling systems in streptozotocin-treated rats.

Authors:  I J Kade; J B T Rocha
Journal:  Neurochem Res       Date:  2013-02-05       Impact factor: 3.996

10.  Association of self-reported cognitive concerns with mobility in people with lower limb loss.

Authors:  Valerie E Kelly; Sara J Morgan; Dagmar Amtmann; Rana Salem; Brian J Hafner
Journal:  Disabil Rehabil       Date:  2016-10-19       Impact factor: 3.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.